Global therapeutic pipeline for non-oncology orphan drug programs by company 2019
Number of non-oncology orphan designated products currently being developed worldwide by company type as of April 2019
This graph shows the number of orphan designated drugs currently being developed by emerging therapeutic companies in the U.S., as of April 2019. As of this time, of the 612 non-oncologic orphan programs being developed, almost half were in Phase II of development.
Number of non-oncology orphan designated products currently being developed worldwide by company type as of April 2019
Source
More information
Statistics on "Orphan drugs"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Total rare diseases funding by the National Institutes for Health 2013-2019
- Overview of rare diseases worldwide and in the U.S. as of 2016
- Share of primary Sjögren patients in the U.S. and EU using healthcare resources 2013
- Comorbidity in primary Sjögren's patients in the U.S. and EU 2015
- Share of primary Sjögren's patients in the U.S. and EU with impairments 2011-2013
- Italy: rare disease patients treated within clinical trials 2017, by disease
- Prevalence of selected rare diseases worldwide 2017
- Number of individuals with rare diseases in Spain 2016
- Expenses made by individuals affected by rare diseases in Spain 2016
- Share of family members who supported relatives with rare diseases in Spain 2016
- U.S. rare disease patient feelings as of 2015
- Italy: number clinical trials for rare diseases 2013-2017
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Italy: number of individuals affected by bleeding disorders 2016, by type and gender
- Top rare disease therapeutic companies enterprise value worldwide 2000-2017
- Dressings packaged for medical use: UK import value 2001-2018
- U.S. adults thinking the government should fund antibiotic development 2018
- Polyvalent immune globulin sales worldwide 1992-2014
- Distribution of paper and paperboard production in Finland 2015
- Global workforce analytic applications revenue by vendor 2012-2014
Statistics on "Orphan drugs"
Related topics
About Statista
